Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry

Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019 (COVID-19), in which organ dysfunction is mediated by severe inflammation. Large studies with diverse populations evaluating statin use and outcomes in COVID-19 are lacking. We used d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2021-07, Vol.16 (7), p.e0254635-e0254635
Hauptverfasser:	Daniels, Lori B, Ren, Junting, Kumar, Kris, Bui, Quan M, Zhang, Jing, Zhang, Xinlian, Sawan, Mariem A, Eisen, Howard, Longhurst, Christopher A, Messer, Karen
Format:	Artikel
Sprache:	eng
Schlagworte:	Antihypertensive drugs Antihypertensives Bioinformatics Cancer Cardiovascular disease Cardiovascular diseases Complications and side effects Coronaviruses COVID-19 Death Diabetes Heart diseases Hospice care Hospital patients Hospitalization Hospitals Hypertension Immunomodulation Infections Inflammation Medicine Medicine and Health Sciences Mortality Patient outcomes Patients Population studies Public health Risk management Risk reduction Severe acute respiratory syndrome coronavirus 2 Social Sciences Statins Statistical analysis Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!